| __timestamp | Viatris Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4050200000 | 5903000 |
| Thursday, January 1, 2015 | 5047100000 | 2762000 |
| Friday, January 1, 2016 | 6078400000 | 1114000 |
| Sunday, January 1, 2017 | 6931500000 | 25573000 |
| Monday, January 1, 2018 | 6861900000 | 6000000 |
| Tuesday, January 1, 2019 | 7056300000 | 38845000 |
| Wednesday, January 1, 2020 | 8149300000 | 50523000 |
| Friday, January 1, 2021 | 12310800000 | 75463000 |
| Saturday, January 1, 2022 | 9765700000 | 105767000 |
| Sunday, January 1, 2023 | 8988300000 | 167512000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Viatris Inc. and Xenon Pharmaceuticals Inc. over the past decade, from 2014 to 2023. Viatris Inc. has consistently demonstrated a robust cost management strategy, with its cost of revenue peaking in 2021 at approximately 12.3 billion USD, before stabilizing to around 9 billion USD in 2023. In contrast, Xenon Pharmaceuticals Inc. has shown a remarkable growth trajectory, with its cost of revenue increasing by over 2,700% from 2014 to 2023, reaching approximately 168 million USD. This stark contrast highlights Viatris's established market presence and Xenon's rapid expansion. As the pharmaceutical landscape continues to shift, these insights provide a valuable perspective on the strategic approaches of these two industry players.
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Viatris Inc.
Cost of Revenue Comparison: Biogen Inc. vs Xenon Pharmaceuticals Inc.
Cost of Revenue: Key Insights for Viatris Inc. and Jazz Pharmaceuticals plc
Viatris Inc. vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Viatris Inc. or Xenon Pharmaceuticals Inc.: Who Invests More in Innovation?
Cost of Revenue Trends: Viatris Inc. vs Vericel Corporation
Cost of Revenue: Key Insights for Viatris Inc. and Taro Pharmaceutical Industries Ltd.
Viatris Inc. vs MiMedx Group, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Bio-Techne Corporation and Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down BioMarin Pharmaceutical Inc. and Xenon Pharmaceuticals Inc.'s Expenses
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.